Shanghai Clinical Cohort - Esophageal Cancer

NCT ID: NCT07312526

Last Updated: 2025-12-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

2116 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-07-01

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A prospective cohort of patients who received esophagectomy for esophageal cancer in participating centers.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A prospective cohort of patients who received esophagectomy for esophageal cancer in participating centers.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Esophageal Cancer Esophagectomy

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

esophageal cancer esophagecomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

esophagectomy

esophagectomy

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Received esophagectomy in these centers for esophageal cancer.

Exclusion Criteria

* No esophagectomy.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shanghai Chest Hospital

OTHER

Sponsor Role lead

Shanghai Zhongshan Hospital

OTHER

Sponsor Role collaborator

Shanghai Cancer Hospital, China

OTHER

Sponsor Role collaborator

Changhai hospital of Navy Medical University

UNKNOWN

Sponsor Role collaborator

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Zhigang Li

Prof.

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Shanghai Chest Hospital

Shanghai, , China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Zhigang Li, Prof.

Role: CONTACT

Phone: 18930619260

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Chang Yuan, Dr.

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IS25163

Identifier Type: -

Identifier Source: org_study_id